is there a dose–response relationship? An individual patient data meta‐analysis. Int J Obes 2018; 42(7):1249–64. doi:10.1038/s41366‐018‐0050‐066 66. Fleisch AF, Rifas‐Shiman SL, Koutrakis P, et al. Prenatal exposure to traffic pollution: associations with reduced fetal growth and rapid infant weight gain. Epidemiology 2015; 26(1):43–50. doi:10.1097/EDE.0000000000000203
67 67. Gao Y‐J, Holloway AC, Zeng Z, et al. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes Res 2005; 13(4):687–92. doi:10.1038/oby.2005.77
68 68. Holloway AC, Lim GE, Petrik JJ, Foster WG, Morrison KM, Gerstein HC. Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes. Diabetologia 2005; 48(12):2661–6. doi:10.1007/s00125‐005‐0022‐5
69 69. Gao Y‐J, Holloway AC, Su L‐Y, Takemori K, Lu C, Lee RMKW. Effects of fetal and neonatal exposure to nicotine on blood pressure and perivascular adipose tissue function in adult life. Eur J Pharmacol 2008; 590(1–3):264–8. doi:10.1016/j.ejphar.2008.05.044
70 70. Holloway AC, Cuu DQ, Morrison KM, Gerstein HC, Tarnopolsky MA. Transgenerational effects of fetal and neonatal exposure to nicotine. Endocrine 2007; 31(3):254–9. doi:10.1007/s12020‐007‐0043‐6
71 71. Braun JM. Early‐life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat Rev Endocrinol 2017; 13(3):161–73. doi:10.1038/nrendo.2016.186
72 72. Johnson PI, Sutton P, Atchley DS, et al. The Navigation Guide—evidence‐based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect 2014; 122(10):1028–39. doi:10.1289/ehp.1307893
73 73. Koustas E, Lam J, Sutton P, et al. The Navigation Guide—evidence‐based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth. Environ Health Perspect 2014; 122(10):1015–27. doi:10.1289/ehp.1307177
74 74. Cardenas A, Hauser R, Gold DR, et al. Association of perfluoroalkyl and polyfluoroalkyl substances with adiposity. JAMA Netw Open 2018; 1(4):e181493. doi:10.1001/jamanetworkopen.2018.1493
75 75. Domazet SL, Grøntved A, Timmermann AG, Nielsen F, Jensen TK. Longitudinal associations of exposure to perfluoroalkylated substances in childhood and adolescence and indicators of adiposity and glucose metabolism 6 and 12 years later: the European Youth Heart Study. Diabetes Care 2016; 39(10):1745–51. doi:10.2337/dc16‐0269
76 76. Halldorsson TI, Rytter D, Haug LS, et al. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect 2012; 120(5):668–73. doi:10.1289/ehp.1104034
77 77. Braun JM, Chen A, Romano ME, et al. Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: the HOME study. Obesity 2016; 24(1):231–7. doi:10.1002/oby.21258
78 78. Mora AM, Oken E, Rifas‐Shiman SL, et al. Prenatal exposure to perfluoroalkyl substances and adiposity in early and mid‐childhood. Environ Health Perspect 2017; 125(3):467–73. doi:10.1289/EHP246
79 79. Høyer BB, Ramlau‐Hansen CH, Vrijheid M, et al. Anthropometry in 5‐ to 9‐year‐old greenlandic and ukrainian children in relation to prenatal exposure to perfluorinated alkyl substances. Environ Health Perspect 2015; 123(8):841–6. doi:10.1289/ehp.1408881
80 80. Andersen CS, Fei C, Gamborg M, Nohr EA, Sørensen TIA, Olsen J. Prenatal exposures to perfluorinated chemicals and anthropometry at 7 years of age. Am J Epidemiol 2013; 178(6):921–7. doi:10.1093/aje/kwt057
81 81. Rifas‐Shiman SL, Rich‐Edwards JW, Scanlon KS, Kleinman KP, Gillman MW. Misdiagnosis of overweight and underweight children younger than 2 years of age due to length measurement bias. MedGenMed 2005; 7(4):56.
82 82. Perng W, Hajj H, Belfort MB, et al. Birth size, early life weight gain, and midchildhood cardiometabolic health. J Pediatr 2016;173:122–30.e1. doi:10.1016/j.jpeds.2016.02.053
83 83. Perng W, Rifas‐Shiman SL, Kramer MS, et al. Early weight gain, linear growth, and mid‐childhood blood pressure: a prospective study in Project Viva. Hypertension 2016; 67(2):301–8. doi:10.1161/HYPERTENSIONAHA.115.06635
84 84. Baird J, Fisher D, Lucas P, Kleijnen J, Roberts H, Law C. Being big or growing fast: systematic review of size and growth in infancy and later obesity. BMJ 2005; 331(7522):929. doi:10.1136/bmj.38586.411273.E0
85 85. Ong KK, Loos RJF. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr 2006; 95(8):904–8. doi:10.1080/08035250600719754
86 86. Barker DJP, Osmond C, Forsén TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005; 353(17):1802–9. doi:10.1056/NEJMoa044160
87 87. Ylihärsilä H, Kajantie E, Osmond C, Forsén T, Barker DJ, Eriksson JG. Body mass index during childhood and adult body composition in men and women aged 56–70 y. Am J Clin Nutr 2008; 87(6):1769–75. doi:10.1093/ajcn/87.6.1769
88 88. Bhargava SK, Sachdev HS, Fall CHD, et al. Relation of serial changes in childhood body‐mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004; 350(9):865–75. doi:10.1056/NEJMoa035698
89 89. Yan J, Liu L, Zhu Y, Huang G, Wang PP. The association between breastfeeding and childhood obesity: a meta‐analysis. BMC Public Health 2014; 14:1267. doi:10.1186/1471‐2458‐14‐1267
90 90. Kramer MS, Moodie EEM, Dahhou M, Platt RW. Breastfeeding and infant size: evidence of reverse causality. Am J Epidemiol 2011; 173(9):978–83. doi:10.1093/aje/kwq495
91 91. Kramer MS, Matush L, Vanilovich I, et al. A randomized breast‐feeding promotion intervention did not reduce child obesity in Belarus. J Nutr 2009; 139(2):417S–21S. doi:10.3945/jn.108.097675
92 92. Martin RM, Kramer MS, Patel R, et al. Effects of promoting long‐term, exclusive breastfeeding on adolescent adiposity, blood pressure, and growth trajectories: a secondary analysis of a randomized clinical trial. JAMA Pediatr 2017; 171(7):e170698. doi:10.1001/jamapediatrics.2017.0698
93 93. Martin RM, Patel R, Kramer MS, et al. Effects of promoting longer‐term and exclusive breastfeeding on cardiometabolic risk factors at age 11.5 years: a cluster‐randomized, controlled trial. Circulation 2014; 129(3):321–9. doi:10.1161/CIRCULATIONAHA.113.005160
94 94. Gunderson EP, Rifas‐Shiman SL, Oken E, et al. Association of fewer hours of sleep at 6 months postpartum with substantial weight retention at 1 year postpartum. Am J Epidemiol 2008; 167(2):178–87. doi:10.1093/aje/kwm298
95 95. Wu Y, Zhai L, Zhang D. Sleep duration and obesity among adults: a meta‐analysis of prospective studies. Sleep Med 2014; 15(12):1456–62. doi:10.1016/j.sleep.2014.07.018
96 96. Li L, Zhang S, Huang Y, Chen K. Sleep duration and obesity in children: a systematic review and meta‐analysis of prospective cohort studies. J Paediatr Child Health 2017; 53(4):378–85. doi:10.1111/jpc.13434
97 97. Miller MA, Kruisbrink M, Wallace J, Ji C, Cappuccio FP. Sleep duration and incidence of obesity in infants, children, and adolescents: a systematic review and meta‐analysis of prospective studies. Sleep 2018; 41(4):1–19. doi:10.1093/sleep/zsy018
98 98. Taveras EM, Rifas‐Shiman SL, Oken E, Gunderson EP, Gillman MW. Short sleep duration in infancy and risk of childhood
